Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

Phase 1 data shows encouraging safety and niche efficacy. Click here to find out why I maintain a buy rating for SDGR stock.

B lymphocytes exhibit dual roles in tumorigenesis, acting as both allies and adversaries in the tumor microenvironment (TME).

B lymphocytes exhibit dual roles in tumorigenesis, acting as both allies and adversaries in the tumor microenvironment (TME).

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Explore how cutting-edge agents like alpelisib, capivasertib, MEK and ERK inhibitors, and JAK inhibitors are reshaping the ...

According to the international phase III NIVOPOSTOP trial, Bristol Myers Squibb’s PD-1 inhibitor nivolumab (Opdivo) added to adjuvant chemoradiotherapy can cut the risk of disease recurrence in ...

and tumour-derived GM-CSF efficiently activated neutrophils and induced programmed death-ligand 1 (PD-L1) expression on neutrophils by activating Janus kinase (JAK)-signal transducer and activator of ...

Immune systems balance activation and inhibition, with activating pathways often discovered first. The PD-1 system was one of the last major components of the immune system without a known fish ...